Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan

<div>Kaplan–Meier analysis with log-rank test of the total hospital mortality in pioglitazone users (in any dose within 3 months prior to the first admission for sepsis) and nonusers.</div>

Emergency Medicine International

fig2

Figure 2

Figure 2: Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan 

Figure 2 | Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan 